CS
IBB icon

Credit Suisse’s iShares Biotechnology ETF IBB Stock Holding History

Credit Suisse’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-27,400
Closed -$4.18M – 3939
2021
Q4 		$4.18M Buy
27,400
+8,500
+45% +$1.32M ﹤0.01% 2168
2021
Q3 		$3.06M Sell
18,900
-21,100
-53% -$3.55M ﹤0.01% 2478
2021
Q2 		$6.55M Buy
40,000
+19,900
+99% +$3.07M ﹤0.01% 1866
2021
Q1 		$3.03M Buy
+20,100
New +$3.19M ﹤0.01% 2509
2020
Q4 		– Sell
-35,000
Closed -$4.74M – 4374
2020
Q3 		$4.74M Buy
+35,000
New +$4.75M ﹤0.01% 1823
2020
Q1 		– Sell
-74,400
Closed -$8.97M – 4111
2019
Q4 		$8.97M Buy
74,400
+45,000
+153% +$5.02M 0.01% 1480
2019
Q3 		$2.92M Hold
29,400
– – ﹤0.01% 2177
2019
Q2 		$3.21M Hold
29,400
– – ﹤0.01% 2099
2019
Q1 		$3.29M Sell
29,400
-70,600
-71% -$7.74M ﹤0.01% 2022
2018
Q4 		$9.64M Buy
+100,000
New +$10.6M 0.01% 1172
2017
Q3 		– Sell
-240,000
Closed -$24.8M – 4212
2017
Q2 		$24.8M Buy
240,000
+135,000
+129% +$13.3M 0.02% 696
2017
Q1 		$10.3M Sell
105,000
-66,000
-39% -$6.32M 0.01% 1206
2016
Q4 		$15.1M Sell
171,000
-226,200
-57% -$20.6M 0.02% 960
2016
Q3 		$38.3M Buy
397,200
+385,800
+3,384% +$36.7M 0.04% 538
2016
Q2 		$978K Buy
+11,400
New +$1.02M ﹤0.01% 2941
2015
Q2 		– Sell
-105,000
Closed -$12M – 4571
2015
Q1 		$12M Buy
+105,000
New +$11.6M 0.01% 1098
2014
Q1 		– Sell
-48,900
Closed -$3.7M – 4753
2013
Q4 		$3.7M Buy
+48,900
New +$3.47M ﹤0.01% 2086

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Credit Suisse's IBB Position: Q1 2024 in Review

Credit Suisse reduced its iShares Biotechnology ETF (IBB) stake by 9% in Q1 2024, selling an estimated $71.8K and leaving 5,307 shares worth $728K. The position accounts for ﹤0.01% of the portfolio, ranked #2455.

Credit Suisse first reported a position in IBB in Q2 2013 and has held it in 44 quarters since. The position peaked at $342M in Q3 2015. 899 funds tracked by Wall St. Rank hold IBB as of Q1 2024.

  • Credit Suisse held 5,307 shares of iShares Biotechnology ETF worth $728K as of Q1 2024.
  • Credit Suisse sold 526 iShares Biotechnology ETF shares in Q1 2024, an estimated $71.8K.
  • iShares Biotechnology ETF made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2455 holding.
  • Credit Suisse first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 44 quarters since.
  • Credit Suisse's iShares Biotechnology ETF position peaked at $342M in Q3 2015.
  • 899 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.